Complete Blood Count Device Global Market Report 2025

The complete blood count device market size has grown strongly in recent years. It will grow from $4.11 billion in 2024 to $4.36 billion in 2025 at a compound annual growth rate (CAGR) of 6.2%. The growth during the historic period can be attributed to an increasing incidence of infectious diseases, heightened awareness of preventive healthcare, expansion of diagnostic laboratories, growth in public health screening initiatives, and a rising elderly population.

The complete blood count device market size is expected to see strong growth in the next few years. It will grow to $5.51 billion in 2029 at a compound annual growth rate (CAGR) of 6%. The projected growth in the forecast period is driven by technological advancements in hematology analyzers, the incorporation of AI and automation in diagnostic processes, increasing demand for point-of-care testing, rising healthcare spending in emerging markets, and the growing prevalence of chronic diseases. Key trends during this time include the use of AI for interpreting results, miniaturization of devices for point-of-care applications, wireless data transmission capabilities, development of cartridge-based consumables, and the addition of multiplex testing functionalities.

The increasing prevalence of blood disorders is expected to drive the growth of the complete blood count device market in the coming years. Blood disorders are conditions that affect the production, function, or structure of blood cells, leading to impaired blood function. The rise in blood disorders is associated with the growing incidence of lifestyle-related diseases, where poor diet, lack of physical activity, and stress contribute to conditions such as anemia and clotting problems. Complete blood count (CBC) devices assist in diagnosing blood disorders by analyzing key blood components and identifying abnormalities, enabling healthcare professionals to detect clotting disorders and provide timely, accurate treatment. For example, in May 2024, the Canadian Cancer Society, a Canada-based organization, reported that 4,100 individuals were diagnosed with multiple myeloma (a type of blood cancer), while 1,750 died from the disease. Therefore, the rising prevalence of blood disorders is fueling the growth of the complete blood count device market.

Leading companies in the complete blood count device market are developing advanced products such as compact hematology analyzers to offer more accurate, faster, and cost-effective solutions for point-of-care testing. Compact hematology analyzers are portable and user-friendly devices that deliver rapid, precise complete blood count (CBC) results with minimal sample volume, making them ideal for use at the point of care. These devices improve diagnostic accuracy, efficiency, and ease of use while being affordable and easy to maintain. For instance, in June 2024, HORIBA, a Japan-based analytical and measurement technology company, launched the Yumizen H550E and H500E hematology analyzers. These compact analyzers combine erythrocyte sedimentation rate (ESR) testing with complete blood count (CBC) and 5-part differential (DIFF) analysis, using HORIBA's patented CoRA (correlated rouleaux analysis) technology to deliver comprehensive results from whole blood samples in just 60 seconds.

In February 2024, Sysmex Corporation, a Japan-based hematology analyzer manufacturer, partnered with CellaVision AB to advance hematology through innovations in digital cell morphology. The collaboration seeks to improve efficiency, precision, and standardization in hematology testing by integrating Sysmex’s hematology expertise with CellaVision’s AI-powered imaging technologies, allowing for more accurate diagnoses and better clinical outcomes. CellaVision AB is a Sweden-based provider of digital hematology microscopy solutions.

Major players in the complete blood count device market are Abbott Laboratories, Siemens Healthineers, Mindray Medical International Limited, Beckman Coulter Inc., Bio-Rad Laboratories, Sysmex Corporation, Horiba Ltd., Nihon Kohden Corporation, Agappe Diagnostics Ltd., Trivitron Healthcare Pvt. Ltd., HemoCue AB, EKF Diagnostics Holdings plc, Erba Mannheim, Boule Diagnostics AB, Biosystems S.A., Diatron MI Zrt., Ajanta Export Industries, Labtron Equipment Ltd., Microlab Instruments Co. Pvt. Ltd., URIT Medical Electronic Co. Ltd.

North America was the largest region in the complete blood count device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in complete blood count (CBC) device report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the complete blood count (CBC) device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

A complete blood count (CBC) device is a medical tool used to conduct a complete blood count, a common laboratory test that measures the levels and characteristics of different blood components. This device automates the blood analysis process, providing accurate and quick results that help healthcare professionals make informed diagnostic and treatment decisions.

The main categories of complete blood count devices include automated blood count analyzers, manual blood count analyzers, point-of-care testing devices, and hematology analyzers. Automated blood count analyzers are sophisticated instruments that utilize various technologies to quickly and precisely count and classify blood cells, improving efficiency and minimizing manual errors in clinical laboratories. These devices perform tests such as white blood cell (WBC) count, WBC differential count, red blood cell (RBC) count, hematocrit (HCT), hemoglobin (HGB), platelet count, mean platelet volume (MPV), mean corpuscular hemoglobin (MCH), and others. They employ technologies like impedance, laser-based methods, flow cytometry, and microscopy. Distribution occurs through channels such as direct sales, online platforms, third-party distributors, and retail pharmacies, with end-users including hospitals, diagnostic labs, research centers, and more.

The complete blood count devices market research report is one of a series of new reports that provides complete blood count devices market statistics, including the complete blood count devices industry global market size, regional shares, competitors with the complete blood count devices market share, detailed complete blood count devices market segments, market trends, opportunities, and any further data you may need to thrive in the complete blood count devices industry. This complete blood count devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The complete blood count (CBC) device market consists of sales of automated hematology analyzers, point-of-care CBC devices, reagents and consumables. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.